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To the Editor:
We read with interest the article by
Schoenburg and colleagues1 regarding the
use of an air bubble trap during coronary
artery bypass grafting. The authors used
measurement of S100 as an indicator of
cerebral injury. It is not clear, however,
whether they took steps to minimize auto-
transfusion of S100 from extracerebral
sources. There is good evidence to show
that blood aspirated from the surgical field
and returned to the patient through cardiot-
omy suckers will result in significantly
higher serum levels of S100.2,3
The study showed no significant differ-
ence in serum S100 between the two
groups at the end of the operation and 6
hours afterward. If the hypothesis that mi-
croemboli are the main cause of cerebral
injury with a resultant rise in S100 is
correct, then a significant reduction in ce-
rebral microemboli should be accompanied
by a significant reduction in S100 at these
time points. In fact the higher, albeit not
statistically significantly, mean S100 lev-
els in the placebo group could be accounted
for by the longer mean cardiopulmonary
bypass time in this group. A longer bypass
time implies that more blood is suctioned
from the mediastinum, with increased re-
turn of mediastinal blood rich in extracere-
bral sources of S100 to the circulation,
thus resulting in higher serum levels of
S100.4
Furthermore, the statement that there
was a significant difference in S100 val-
ues at 48 hours is misleading. The Sangtec
100 immunoradiometric assay (Sangtec
Medical AB, Stockholm, Sweden) that was
used in the study has a lower detection
limit of 0.2 g/L. The mean S100 value
for both the bubble trap and placebo groups
was below this level, and thus normal. We
therefore do not agree with the conclusion
that the dynamic air bubble trap reduces
S100 early after coronary artery bypass
grafting. A more sensitive analysis of
scular Surgery ● July 2004S100 could have been carried out with the
immunoluminometric method (Sangtec
LIA 100; Sangtec Medical AB), which has
a functional detection limit of 0.02 g/L.
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Improved pain control after cardiac
surgery
To the Editor:
We read with interest the article by Dowl-
ing and associates1 about improved pain
control by means of intraoperative inter-
costal nerve block followed by postopera-
tive continuous infusion of ropivacaine.
We performed a similar study that will be
published soon.2 We randomly assigned 47
patients to two groups. The study group (n
 23) was treated by soft-tissue infiltration
with bupivacaine (10 mL 0.5% bupiva-
caine) followed by 36 hours of continuous
infusion (bupivacaine 0.5% at 120 mL/24
h) through a small-diameter catheter posi-
tioned anteriorly to the sternum. In the con-
trol group (n  24) the catheter was posi-
Letters to the Editortioned as well but there was neither
infiltration nor postoperative infusion. Af-
ter the operation we assessed pain control
by a visual analog scale at specific time
points (extubation and 12, 24, and 36
hours). We also recorded the assisted ven-
tilation time as well as the intravenous ad-
ministrations of analgesic drugs. Blood gas
analysis was performed at extubation and
at 6, 12, and 24 postoperative hours. Unlike
Dowling and associates’ findings,1 we
were unable to demonstrate any effective-
ness of this treatment, even though the drug
and its dosage were similar to those used in
their study. However, the protocol of these
authors consisted in a T1-T12 intercostal
nerve block, whereas we performed a local
soft-tissue infiltration. We therefore may
speculate that the efficacy of Dowling and
associates’ treatment was related more to
the intercostal nerve block than to the post-
operative continuous infusion, which was
common to both studies. An interesting
second step of their study would be the
comparison between the sole intercostal
nerve block and this procedure followed by
continuous anesthetic infusion. Regardless,
we may conclude that these attempts to
reduce postoperative pain are promising
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Reply to the Editor:
We are responding to the letter of Racigno
and Carnelos. As they described, we per-
formed a double-blind randomized con-
trolled trial in which patients undergoing
elective bypass surgery received either bi-
lateral intercostal nerve block with ropiva-
caine or a saline placebo. At wound clo-
Tsure, two catheters with multiple side
openings were inserted percutaneously and
placed directly over the sternum. The same
agent (ropivacaine or saline solution) was
then administered as a continuous regional
infusion for 48 hours through an elasto-
meric pump. The main findings of our
study were that patients in the ropivacaine
group had improved postoperative pain
control and required less narcotic analge-
sia. Additionally, patients in the ropiva-
caine group had significantly lower pain
scores than did patients who received pla-
cebo, and length of stay was also decreased
in the ropivacaine group.
Racigno and Carnelos report doing a
similar randomized trial in which they were
unable to demonstrate any effectiveness of
this treatment. In their letter, however, it is
not clear how similar the therapeutic ap-
proaches truly were. We believe that a key
component in our study was the develop-
ment and clinical use of catheters with mul-
tiple side openings, which allow even dis-
tributions of the anesthetic agent
throughout the operative field. Racigno and
Carnelos reported using a small-diameter
catheter, but it is not clear whether this
catheter was effective in providing a true
regional anesthetic. They further suggested
that the difference in outcome may have
been related to the use in our study of
bilateral intercostal nerve block before per-
forming wound closure.
We believe this is unlikely to explain
the major differences seen between our two
groups for a number of reasons. First, it is
widely documented that intercostal nerve
blocks, even with long-acting anesthetic
agents, do not provide pain control beyond
6 to 8 hours. Second, we assessed pain
scores on the second postoperative day to
eliminate the effect of this and other con-
founding variables, such as residual anal-
gesia given at the time of operative therapy.
We were able to demonstrate marked de-
crease in narcotic use on the second post-
operative day, when clearly the patient
would not be receiving any benefit from the
intercostal nerve block.
In addition, since the submission of our
article a similar study has been performed
that has demonstrated the advantages of a
continuous local infusion for pain manage-
ment after median sternotomy.1 White and
colleagues1 performed a prospective, ran-
domized, placebo-controlled trial with the
same catheter system that was used in our
he Journal of Thoracic and Cardiovascularstudy. These investigators also showed a
significant reduction in pain scores, mor-
phine use, patient dissatisfaction, time to
ambulation, and duration of hospital stay.
In our opinion, the results of our study
and that of White and colleagues1 strongly
suggest that this approach will result in
improved patient comfort and satisfaction,
as well as decreased narcotic use after me-
dian sternotomy. As noted in both studies,
the use of the catheter does not require any
physician or nursing intervention after its
placement, and there has been no morbidity
associated with this approach. We consider
this approach an excellent first step to im-
proving the overall approach to pain man-
agement for our patients.
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Suggestion for functional model to
test effects of decellularization of rat
aortic valve allografts on leaflet
destruction and extracellular matrix
remodeling
To the Editor:
In their article “Decellularization of Rat
Aortic Valve Allografts Reduces Leaflet
Destruction and Extracellular Matrix Re-
modeling,” Grauss and colleagues1 ele-
gantly evaluated various methods of decel-
lularization of aortic valve conduits and
tested their structural integrity after im-
plantation in a rat model. Their findings
suggest that decellularization is possible
and may reduce the recipient’s immune
response to allogeneic tissue, as demon-
strated by preservation of the leaflets’
structural integrity in decellularized allo-
grafts relative to cellular allografts. Despite
the lack of immunologic data and the small
number of animals, they showed convinc-
ing histologic evidence reflecting these
findings.
However, one of the major limitations
affecting the generalizability of their find-
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